Detalles de la búsqueda
1.
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
Pharmacol Rev;
73(1): 310-520, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33370241
2.
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneity.
Brain Behav Immun;
113: 166-175, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423513
3.
ILB®, a Low Molecular Weight Dextran Sulphate, Restores Glutamate Homeostasis, Amino Acid Metabolism and Neurocognitive Functions in a Rat Model of Severe Traumatic Brain Injury.
Int J Mol Sci;
23(15)2022 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955592
4.
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatment.
Brain Behav Immun;
91: 498-504, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33161162
5.
SPAK and OSR1 kinases bind and phosphorylate the ß2-Adrenergic receptor.
Biochem Biophys Res Commun;
532(1): 88-93, 2020 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32828531
6.
CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome.
J Pharmacol Exp Ther;
373(1): 122-134, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32102919
7.
Geissospermiculatine, a New Alkaloid from Geissospermum reticulatum Bark.
Molecules;
26(1)2020 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33396182
8.
Overexpression of Orphan Receptor GPR61 Increases cAMP Levels upon Forskolin Stimulation in HEK293 Cells: in vitro and in silico Validation of 5-(Nonyloxy)Tryptamine as a Low-Affinity Inverse Agonist.
Pharmacology;
104(5-6): 377-382, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31352450
9.
The discovery of diazepinone-based 5-HT3 receptor partial agonists.
Bioorg Med Chem Lett;
24(11): 2578-81, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24755431
10.
Impact of a varied set of stimuli on a suite of immunological parameters within peripheral blood mononuclear cells: toward a non-animal approach for assessing immune modulation by materials intended for human use.
Front Toxicol;
6: 1335110, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38737195
11.
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro.
MAbs;
16(1): 2300155, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241085
12.
Relaxation of mitochondrial hyperfusion in the diabetic retina via N6-furfuryladenosine confers neuroprotection regardless of glycaemic status.
Nat Commun;
15(1): 1124, 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321058
13.
Anhedonia as a potential transdiagnostic phenotype with immune-related changes in recent onset mental health disorders.
Biol Psychiatry;
2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38823495
14.
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis.
BMJ Open;
13(3): e067944, 2023 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36963796
15.
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial.
Transl Psychiatry;
13(1): 297, 2023 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37723153
16.
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trial.
Trials;
24(1): 646, 2023 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803384
17.
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.
Br J Pharmacol;
180 Suppl 2: S23-S144, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123151
18.
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death.
Invest New Drugs;
30(4): 1471-83, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21850491
19.
A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis.
PLoS One;
17(5): e0267183, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35613082
20.
The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis.
Front Pharmacol;
13: 983853, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36110516